Drug Rhythm-Control Failure Widens Opening For Ablation, Say Cardiologists

Drug-based rhythm-control therapy does not help keep patients with atrial fibrillation and heart failure alive any better than conventional heart failure drugs, researchers report in the June 19 New England Journal of Medicine

More from Archive

More from Medtech Insight